Login / Signup

A Review of the First Long-term Implantable Continuous Glucose Monitoring System Available in the United States.

Kevin Cowart
Published in: Journal of diabetes science and technology (2019)
Based on the available evidence, LTI CGM appears to be safe and accurate. Additional clinical trial investigation is warranted to evaluate the glycemic efficacy of LTI CGM.
Keyphrases
  • clinical trial
  • type diabetes
  • phase ii
  • high resolution
  • open label
  • study protocol
  • double blind
  • skeletal muscle
  • mass spectrometry
  • insulin resistance
  • weight loss